Please upgrade your browser.
Bill Wondergem, 21, a Calvin biology major and biochemistry minor, has worked since his junior year as an intern in the lab of Bin Teh, a distinguished scientific investigator at the Van Andel Research Institute (VARI) and a specialist in kidney cancer.
These products have also been linked to an increased risk of kidney cancer in people who have consumed them.
Showed a 54 percent regression of the tumor volume.
Shows Tumor Regression in Patients with Advanced Renal Cancer.
Early Data on Amgens Anti-Angiogenesis Pipeline Molecules Suggest Biologic Activity Across Tumor Types
Amgen today announced results from preclinical studies suggesting a significantly greater reduction in tumor growth when AMG 386, a recombinant Fc-peptide fusion protein (peptibody) designed to bind angiopoietins 1 and 2, thereby inhibiting Tie2 dependent stimulation of endothelial cells, was combined with either of two vascular endothelial growth factor (VEGF) inhibitors -- bevacizumab or motesanib diphosphate (AMG 706) -- compared with either treatment alone (p< 0.05).
Alpha Tau Omega of the University of California Santa Barbara presents All Sorority Volleyball Tournament 2008
Volleyball tournament raises thousands for kidney cancer!!
SGN-75 is an antibody-drug conjugate (ADC) that has demonstrated potent antitumor activity at well-tolerated doses in preclinical models of renal cell cancer.
But study reveals wide variations between countries.
Drugs hailed as breakthrough treatments for cancer, Britain's biggest cause of death, may be less effective and cause more harm than suspected, they said.
A little biotech company, Antigenics (AGEN), announced that Russia has approved its kidney cancer drug, Oncophage. It's the first so-called therapeutic cancer vaccine to win full-out approval anywhere in the world.
|Powered by NeonCRM|